Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

J Med Virol. 2021 Jan;93(1):187-189. doi: 10.1002/jmv.26299. Epub 2020 Jul 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetates / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • Cyclopropanes / therapeutic use*
  • Humans
  • Quinolines / therapeutic use*
  • SARS-CoV-2 / drug effects*
  • Sulfides / therapeutic use*

Substances

  • Acetates
  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Cyclopropanes
  • Quinolines
  • Sulfides
  • montelukast